Y DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPOLE MASS SPECTROMETRY IMMUNOASSAY BEA RAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULA IOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIO E II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY OLE MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMAT COVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION RGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE TICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MA AD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVER LATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGE BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAP Y DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY IMMUNOASS OMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS TATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUAN HASE I PHASE II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION A UADRUPOLE MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID LATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS TATION CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL M SEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESO OLE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTIC NALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION OUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY TICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPO GY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOAN ERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ON POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THER S HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPOLE MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLO ICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST SEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESO LE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTI NALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATIO OUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY TICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPO GY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOAN ERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ON POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THER S HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED T BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRIT QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRA PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATO OVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITAT ALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PH TIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE NOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSI ONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TR TITATION BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTI ON ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY I UID CHROMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOL UANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QU HASE I PHASE II PHASE III DISCOVERY RESEARCH PRECLINICAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION A QUADRUPOLE MASS TANDEM QUADRUPOLE MASS MASS SPECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LI ANALYSIS DISCOVERY BIOANALYSIS BIOANALYTICAL EXPERTISE WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARM CLINICAL TRIALS TARGETED QUANTITATION ROUTINE QUANTITATION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL MO CAL TRIAL PEPTIDE THERAPEUTICS PROTEIN THERAPEUTICS SMALL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE ECTROMETRY IMMUNOASSAY BEAD BASED TECHNOLOGY SISCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY BIOTHERAPEUTICS BIOANALYSIS RE E WORKFLOW SOLUTIONS REGULATORY CRITERIA GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QU ION UNTARGETED QUANTITATION BIOTRANSFORMATION POST TRANSLATIONAL MODIFICATIONS PHASE I PHASE II PHASE III DISCOVERY RESEARCH P LL MOLECULE QUANTITATION ANTIBODY DRUG CONJUGATES HIGH RESOLUTION ACCURATE MASS TRIPLE QUADRUPOLE MASS TANDEM QUADRUPOLE MA SCAPA TRYPSIN DIGESTION LIQUID CHROMATOGRAPHY MASS TRANS BIOTHERAPEUTICS BIOANALYSIS REGULATED BIOANALYSIS DISCOVERY BIOANALYSIS GENERIC PHARMACEUTICALS BIOPHARMA QUANTITATION BIOLOGICS QUANTITATION BIOSIMILARS QUANTITATION CLINICAL TRIALS TARGETED QUANTITATIO


Revitalize Your Quantitation Workflows


The world of Pharma and Biopharma has evolved significantly in the recent past, and the domain of therapeutics is wider than ever before. The demand to achieve quality results faster while reducing cost continues to grow.


Today’s world of quantitation warrants a complete workflow that provides increased confidence in analysis and quantitation for all molecule types, every time, and better than ever before. Thermo Fisher offers you the quantitation capabilities you’ve always aspired to have.


Discover more: thermofisher.com/revitalize-quan


© 2016 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. AD72163-EN 0916S


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117